Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
HRTX | HERON THERAPEUTICS, INC. /DE/ | EVP, Drug Development | $121 K | Apr 13, 2023 | ||
INBX | Inhibrx, Inc. | Director | $0 | May 30, 2024 | ||
INXB | Inhibrx Biosciences, Inc. | Director | May 30, 2024 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|